IGC PHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -26.9% | -26.6% | -24.6% |
| FY2022 | -62.8% | -62.5% | -56.0% |
| FY2023 | -77.2% | -76.4% | -67.0% |
| FY2024 | -177.6% | -174.3% | -131.3% |
| FY2025 | -95.9% | -94.3% | -73.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -26.9% | -26.6% | -24.6% |
| FY2022 | -62.8% | -62.5% | -56.0% |
| FY2023 | -77.2% | -76.4% | -67.0% |
| FY2024 | -177.6% | -174.3% | -131.3% |
| FY2025 | -95.9% | -94.3% | -73.3% |